nodes	percent_of_prediction	percent_of_DWPC	metapath
Mianserin—CYP1A2—Leflunomide—rheumatoid arthritis	0.0584	0.201	CbGbCtD
Mianserin—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.0338	0.116	CbGbCtD
Mianserin—CYP2B6—Dexamethasone—rheumatoid arthritis	0.0307	0.106	CbGbCtD
Mianserin—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.0249	0.0859	CbGbCtD
Mianserin—CYP2D6—Cyclosporine—rheumatoid arthritis	0.0225	0.0776	CbGbCtD
Mianserin—CYP3A4—Triamcinolone—rheumatoid arthritis	0.0189	0.0651	CbGbCtD
Mianserin—CYP3A4—Betamethasone—rheumatoid arthritis	0.0162	0.0558	CbGbCtD
Mianserin—CYP3A4—Prednisolone—rheumatoid arthritis	0.016	0.0551	CbGbCtD
Mianserin—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.0152	0.0522	CbGbCtD
Mianserin—CYP3A4—Prednisone—rheumatoid arthritis	0.0151	0.052	CbGbCtD
Mianserin—CYP2D6—Dexamethasone—rheumatoid arthritis	0.0148	0.0511	CbGbCtD
Mianserin—CYP3A4—Cyclosporine—rheumatoid arthritis	0.0143	0.0493	CbGbCtD
Mianserin—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00943	0.0325	CbGbCtD
Mianserin—Constipation—Leflunomide—rheumatoid arthritis	0.000822	0.00223	CcSEcCtD
Mianserin—Vertigo—Cyclosporine—rheumatoid arthritis	0.000816	0.00221	CcSEcCtD
Mianserin—Eye disorder—Methylprednisolone—rheumatoid arthritis	0.000814	0.00221	CcSEcCtD
Mianserin—Leukopenia—Cyclosporine—rheumatoid arthritis	0.000813	0.00221	CcSEcCtD
Mianserin—Mental disorder—Hydrocortisone—rheumatoid arthritis	0.000813	0.0022	CcSEcCtD
Mianserin—Cardiac disorder—Methylprednisolone—rheumatoid arthritis	0.000809	0.00219	CcSEcCtD
Mianserin—Bradycardia—Dexamethasone—rheumatoid arthritis	0.000807	0.00219	CcSEcCtD
Mianserin—Bradycardia—Betamethasone—rheumatoid arthritis	0.000807	0.00219	CcSEcCtD
Mianserin—Neutropenia—Prednisone—rheumatoid arthritis	0.000806	0.00219	CcSEcCtD
Mianserin—Erectile dysfunction—Prednisone—rheumatoid arthritis	0.000794	0.00215	CcSEcCtD
Mianserin—Feeling abnormal—Leflunomide—rheumatoid arthritis	0.000792	0.00215	CcSEcCtD
Mianserin—Angiopathy—Methylprednisolone—rheumatoid arthritis	0.000791	0.00214	CcSEcCtD
Mianserin—Convulsion—Cyclosporine—rheumatoid arthritis	0.000787	0.00213	CcSEcCtD
Mianserin—Mediastinal disorder—Methylprednisolone—rheumatoid arthritis	0.000785	0.00213	CcSEcCtD
Mianserin—Weight increased—Prednisone—rheumatoid arthritis	0.000785	0.00213	CcSEcCtD
Mianserin—Hypertension—Cyclosporine—rheumatoid arthritis	0.000784	0.00213	CcSEcCtD
Mianserin—Myalgia—Cyclosporine—rheumatoid arthritis	0.000773	0.0021	CcSEcCtD
Mianserin—Arthralgia—Cyclosporine—rheumatoid arthritis	0.000773	0.0021	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—rheumatoid arthritis	0.000768	0.00208	CcSEcCtD
Mianserin—Mental disorder—Methylprednisolone—rheumatoid arthritis	0.000763	0.00207	CcSEcCtD
Mianserin—Dry mouth—Cyclosporine—rheumatoid arthritis	0.000756	0.00205	CcSEcCtD
Mianserin—Breast disorder—Methotrexate—rheumatoid arthritis	0.000753	0.00204	CcSEcCtD
Mianserin—Confusional state—Cyclosporine—rheumatoid arthritis	0.000748	0.00203	CcSEcCtD
Mianserin—Vertigo—Prednisolone—rheumatoid arthritis	0.000743	0.00201	CcSEcCtD
Mianserin—Oedema—Cyclosporine—rheumatoid arthritis	0.000742	0.00201	CcSEcCtD
Mianserin—Syncope—Prednisolone—rheumatoid arthritis	0.000741	0.00201	CcSEcCtD
Mianserin—Eye disorder—Betamethasone—rheumatoid arthritis	0.000741	0.00201	CcSEcCtD
Mianserin—Eye disorder—Dexamethasone—rheumatoid arthritis	0.000741	0.00201	CcSEcCtD
Mianserin—Nervous system disorder—Cyclosporine—rheumatoid arthritis	0.000727	0.00197	CcSEcCtD
Mianserin—Loss of consciousness—Prednisolone—rheumatoid arthritis	0.000727	0.00197	CcSEcCtD
Mianserin—Thrombocytopenia—Cyclosporine—rheumatoid arthritis	0.000726	0.00197	CcSEcCtD
Mianserin—Vertigo—Hydrocortisone—rheumatoid arthritis	0.000725	0.00197	CcSEcCtD
Mianserin—Syncope—Hydrocortisone—rheumatoid arthritis	0.000724	0.00196	CcSEcCtD
Mianserin—Skin disorder—Cyclosporine—rheumatoid arthritis	0.00072	0.00195	CcSEcCtD
Mianserin—Angiopathy—Dexamethasone—rheumatoid arthritis	0.000719	0.00195	CcSEcCtD
Mianserin—Angiopathy—Betamethasone—rheumatoid arthritis	0.000719	0.00195	CcSEcCtD
Mianserin—Convulsion—Prednisolone—rheumatoid arthritis	0.000716	0.00194	CcSEcCtD
Mianserin—Hypertension—Prednisolone—rheumatoid arthritis	0.000714	0.00194	CcSEcCtD
Mianserin—Loss of consciousness—Hydrocortisone—rheumatoid arthritis	0.00071	0.00192	CcSEcCtD
Mianserin—Bradycardia—Prednisone—rheumatoid arthritis	0.000703	0.00191	CcSEcCtD
Mianserin—Convulsion—Hydrocortisone—rheumatoid arthritis	0.0007	0.0019	CcSEcCtD
Mianserin—Hypertension—Hydrocortisone—rheumatoid arthritis	0.000697	0.00189	CcSEcCtD
Mianserin—Asthenia—Leflunomide—rheumatoid arthritis	0.000689	0.00187	CcSEcCtD
Mianserin—Myalgia—Hydrocortisone—rheumatoid arthritis	0.000687	0.00186	CcSEcCtD
Mianserin—Pancytopenia—Methotrexate—rheumatoid arthritis	0.000684	0.00186	CcSEcCtD
Mianserin—Vertigo—Triamcinolone—rheumatoid arthritis	0.000683	0.00185	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—rheumatoid arthritis	0.000683	0.00185	CcSEcCtD
Mianserin—Syncope—Triamcinolone—rheumatoid arthritis	0.000682	0.00185	CcSEcCtD
Mianserin—Vertigo—Methylprednisolone—rheumatoid arthritis	0.000682	0.00185	CcSEcCtD
Mianserin—Syncope—Methylprednisolone—rheumatoid arthritis	0.00068	0.00184	CcSEcCtD
Mianserin—Pruritus—Leflunomide—rheumatoid arthritis	0.00068	0.00184	CcSEcCtD
Mianserin—Connective tissue disorder—Prednisone—rheumatoid arthritis	0.000678	0.00184	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Cyclosporine—rheumatoid arthritis	0.000676	0.00183	CcSEcCtD
Mianserin—Oedema—Prednisolone—rheumatoid arthritis	0.000675	0.00183	CcSEcCtD
Mianserin—Neutropenia—Methotrexate—rheumatoid arthritis	0.000674	0.00183	CcSEcCtD
Mianserin—Dizziness—Azathioprine—rheumatoid arthritis	0.000673	0.00182	CcSEcCtD
Mianserin—Loss of consciousness—Triamcinolone—rheumatoid arthritis	0.000668	0.00181	CcSEcCtD
Mianserin—Loss of consciousness—Methylprednisolone—rheumatoid arthritis	0.000667	0.00181	CcSEcCtD
Mianserin—Paraesthesia—Cyclosporine—rheumatoid arthritis	0.000666	0.00181	CcSEcCtD
Mianserin—Shock—Prednisolone—rheumatoid arthritis	0.000664	0.0018	CcSEcCtD
Mianserin—Erectile dysfunction—Methotrexate—rheumatoid arthritis	0.000664	0.0018	CcSEcCtD
Mianserin—Somnolence—Cyclosporine—rheumatoid arthritis	0.000659	0.00179	CcSEcCtD
Mianserin—Oedema—Hydrocortisone—rheumatoid arthritis	0.000659	0.00179	CcSEcCtD
Mianserin—Convulsion—Triamcinolone—rheumatoid arthritis	0.000659	0.00179	CcSEcCtD
Mianserin—Tachycardia—Prednisolone—rheumatoid arthritis	0.000659	0.00179	CcSEcCtD
Mianserin—Convulsion—Methylprednisolone—rheumatoid arthritis	0.000657	0.00178	CcSEcCtD
Mianserin—Hypertension—Triamcinolone—rheumatoid arthritis	0.000656	0.00178	CcSEcCtD
Mianserin—Hypertension—Methylprednisolone—rheumatoid arthritis	0.000655	0.00178	CcSEcCtD
Mianserin—Shock—Hydrocortisone—rheumatoid arthritis	0.000648	0.00176	CcSEcCtD
Mianserin—Myalgia—Triamcinolone—rheumatoid arthritis	0.000647	0.00176	CcSEcCtD
Mianserin—Nervous system disorder—Hydrocortisone—rheumatoid arthritis	0.000646	0.00175	CcSEcCtD
Mianserin—Arthralgia—Methylprednisolone—rheumatoid arthritis	0.000646	0.00175	CcSEcCtD
Mianserin—Myalgia—Methylprednisolone—rheumatoid arthritis	0.000646	0.00175	CcSEcCtD
Mianserin—Eye disorder—Prednisone—rheumatoid arthritis	0.000645	0.00175	CcSEcCtD
Mianserin—Tachycardia—Hydrocortisone—rheumatoid arthritis	0.000643	0.00174	CcSEcCtD
Mianserin—Drowsiness—Methotrexate—rheumatoid arthritis	0.000642	0.00174	CcSEcCtD
Mianserin—Rash—Azathioprine—rheumatoid arthritis	0.000641	0.00174	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	0.000641	0.00174	CcSEcCtD
Mianserin—Dermatitis—Azathioprine—rheumatoid arthritis	0.000641	0.00174	CcSEcCtD
Mianserin—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	0.00064	0.00174	CcSEcCtD
Mianserin—Skin disorder—Hydrocortisone—rheumatoid arthritis	0.00064	0.00174	CcSEcCtD
Mianserin—Fatigue—Cyclosporine—rheumatoid arthritis	0.000639	0.00173	CcSEcCtD
Mianserin—Headache—Azathioprine—rheumatoid arthritis	0.000637	0.00173	CcSEcCtD
Mianserin—Dizziness—Leflunomide—rheumatoid arthritis	0.000635	0.00172	CcSEcCtD
Mianserin—Constipation—Cyclosporine—rheumatoid arthritis	0.000634	0.00172	CcSEcCtD
Mianserin—Dry mouth—Triamcinolone—rheumatoid arthritis	0.000633	0.00172	CcSEcCtD
Mianserin—Angiopathy—Prednisone—rheumatoid arthritis	0.000626	0.0017	CcSEcCtD
Mianserin—Confusional state—Methylprednisolone—rheumatoid arthritis	0.000624	0.00169	CcSEcCtD
Mianserin—Oedema—Triamcinolone—rheumatoid arthritis	0.000621	0.00168	CcSEcCtD
Mianserin—Vertigo—Dexamethasone—rheumatoid arthritis	0.00062	0.00168	CcSEcCtD
Mianserin—Vertigo—Betamethasone—rheumatoid arthritis	0.00062	0.00168	CcSEcCtD
Mianserin—Syncope—Betamethasone—rheumatoid arthritis	0.000619	0.00168	CcSEcCtD
Mianserin—Syncope—Dexamethasone—rheumatoid arthritis	0.000619	0.00168	CcSEcCtD
Mianserin—Hypotension—Hydrocortisone—rheumatoid arthritis	0.000616	0.00167	CcSEcCtD
Mianserin—Feeling abnormal—Cyclosporine—rheumatoid arthritis	0.000611	0.00166	CcSEcCtD
Mianserin—Shock—Triamcinolone—rheumatoid arthritis	0.00061	0.00166	CcSEcCtD
Mianserin—Shock—Methylprednisolone—rheumatoid arthritis	0.000609	0.00165	CcSEcCtD
Mianserin—Hepatobiliary disease—Methotrexate—rheumatoid arthritis	0.000608	0.00165	CcSEcCtD
Mianserin—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	0.000607	0.00165	CcSEcCtD
Mianserin—Loss of consciousness—Dexamethasone—rheumatoid arthritis	0.000606	0.00164	CcSEcCtD
Mianserin—Loss of consciousness—Betamethasone—rheumatoid arthritis	0.000606	0.00164	CcSEcCtD
Mianserin—Paraesthesia—Prednisolone—rheumatoid arthritis	0.000606	0.00164	CcSEcCtD
Mianserin—Rash—Leflunomide—rheumatoid arthritis	0.000606	0.00164	CcSEcCtD
Mianserin—Tachycardia—Triamcinolone—rheumatoid arthritis	0.000606	0.00164	CcSEcCtD
Mianserin—Dermatitis—Leflunomide—rheumatoid arthritis	0.000605	0.00164	CcSEcCtD
Mianserin—Mental disorder—Prednisone—rheumatoid arthritis	0.000605	0.00164	CcSEcCtD
Mianserin—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.000604	0.00164	CcSEcCtD
Mianserin—Headache—Leflunomide—rheumatoid arthritis	0.000602	0.00163	CcSEcCtD
Mianserin—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000601	0.00163	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	0.0006	0.00163	CcSEcCtD
Mianserin—Agranulocytosis—Methotrexate—rheumatoid arthritis	0.0006	0.00163	CcSEcCtD
Mianserin—Convulsion—Dexamethasone—rheumatoid arthritis	0.000598	0.00162	CcSEcCtD
Mianserin—Convulsion—Betamethasone—rheumatoid arthritis	0.000598	0.00162	CcSEcCtD
Mianserin—Hypertension—Betamethasone—rheumatoid arthritis	0.000596	0.00161	CcSEcCtD
Mianserin—Hypertension—Dexamethasone—rheumatoid arthritis	0.000596	0.00161	CcSEcCtD
Mianserin—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.000592	0.0016	CcSEcCtD
Mianserin—Myalgia—Dexamethasone—rheumatoid arthritis	0.000587	0.00159	CcSEcCtD
Mianserin—Myalgia—Betamethasone—rheumatoid arthritis	0.000587	0.00159	CcSEcCtD
Mianserin—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000579	0.00157	CcSEcCtD
Mianserin—Hepatitis—Methotrexate—rheumatoid arthritis	0.000577	0.00156	CcSEcCtD
Mianserin—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000569	0.00154	CcSEcCtD
Mianserin—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000568	0.00154	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.000565	0.00153	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000564	0.00153	CcSEcCtD
Mianserin—Oedema—Betamethasone—rheumatoid arthritis	0.000563	0.00153	CcSEcCtD
Mianserin—Oedema—Dexamethasone—rheumatoid arthritis	0.000563	0.00153	CcSEcCtD
Mianserin—Desipramine—SLC22A4—rheumatoid arthritis	0.000559	0.367	CrCbGaD
Mianserin—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000557	0.00151	CcSEcCtD
Mianserin—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.000556	0.00151	CcSEcCtD
Mianserin—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.000556	0.00151	CcSEcCtD
Mianserin—Anaemia—Prednisone—rheumatoid arthritis	0.000555	0.00151	CcSEcCtD
Mianserin—Shock—Dexamethasone—rheumatoid arthritis	0.000554	0.0015	CcSEcCtD
Mianserin—Shock—Betamethasone—rheumatoid arthritis	0.000554	0.0015	CcSEcCtD
Mianserin—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000552	0.0015	CcSEcCtD
Mianserin—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000552	0.0015	CcSEcCtD
Mianserin—Agitation—Prednisone—rheumatoid arthritis	0.000552	0.0015	CcSEcCtD
Mianserin—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.000551	0.00149	CcSEcCtD
Mianserin—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.000551	0.00149	CcSEcCtD
Mianserin—Tachycardia—Betamethasone—rheumatoid arthritis	0.000549	0.00149	CcSEcCtD
Mianserin—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000549	0.00149	CcSEcCtD
Mianserin—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000543	0.00147	CcSEcCtD
Mianserin—Vertigo—Prednisone—rheumatoid arthritis	0.00054	0.00146	CcSEcCtD
Mianserin—Eye disorder—Methotrexate—rheumatoid arthritis	0.000539	0.00146	CcSEcCtD
Mianserin—Syncope—Prednisone—rheumatoid arthritis	0.000539	0.00146	CcSEcCtD
Mianserin—Tinnitus—Methotrexate—rheumatoid arthritis	0.000538	0.00146	CcSEcCtD
Mianserin—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.000535	0.00145	CcSEcCtD
Mianserin—Fatigue—Triamcinolone—rheumatoid arthritis	0.000535	0.00145	CcSEcCtD
Mianserin—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000534	0.00145	CcSEcCtD
Mianserin—Asthenia—Cyclosporine—rheumatoid arthritis	0.000532	0.00144	CcSEcCtD
Mianserin—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000528	0.00143	CcSEcCtD
Mianserin—Hypotension—Dexamethasone—rheumatoid arthritis	0.000526	0.00143	CcSEcCtD
Mianserin—Hypotension—Betamethasone—rheumatoid arthritis	0.000526	0.00143	CcSEcCtD
Mianserin—Pruritus—Cyclosporine—rheumatoid arthritis	0.000525	0.00142	CcSEcCtD
Mianserin—Angiopathy—Methotrexate—rheumatoid arthritis	0.000523	0.00142	CcSEcCtD
Mianserin—Convulsion—Prednisone—rheumatoid arthritis	0.000521	0.00141	CcSEcCtD
Mianserin—Mediastinal disorder—Methotrexate—rheumatoid arthritis	0.00052	0.00141	CcSEcCtD
Mianserin—Hypertension—Prednisone—rheumatoid arthritis	0.000519	0.00141	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000513	0.00139	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000513	0.00139	CcSEcCtD
Mianserin—Arthralgia—Prednisone—rheumatoid arthritis	0.000511	0.00139	CcSEcCtD
Mianserin—Myalgia—Prednisone—rheumatoid arthritis	0.000511	0.00139	CcSEcCtD
Mianserin—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000511	0.00139	CcSEcCtD
Mianserin—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.00051	0.00138	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000508	0.00138	CcSEcCtD
Mianserin—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000506	0.00137	CcSEcCtD
Mianserin—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000506	0.00137	CcSEcCtD
Mianserin—Mental disorder—Methotrexate—rheumatoid arthritis	0.000505	0.00137	CcSEcCtD
Mianserin—Dizziness—Cyclosporine—rheumatoid arthritis	0.00049	0.00133	CcSEcCtD
Mianserin—Oedema—Prednisone—rheumatoid arthritis	0.00049	0.00133	CcSEcCtD
Mianserin—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000486	0.00132	CcSEcCtD
Mianserin—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000486	0.00132	CcSEcCtD
Mianserin—Fatigue—Betamethasone—rheumatoid arthritis	0.000485	0.00132	CcSEcCtD
Mianserin—Fatigue—Dexamethasone—rheumatoid arthritis	0.000485	0.00132	CcSEcCtD
Mianserin—Shock—Prednisone—rheumatoid arthritis	0.000482	0.00131	CcSEcCtD
Mianserin—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000481	0.0013	CcSEcCtD
Mianserin—Tachycardia—Prednisone—rheumatoid arthritis	0.000479	0.0013	CcSEcCtD
Mianserin—Skin disorder—Prednisone—rheumatoid arthritis	0.000476	0.00129	CcSEcCtD
Mianserin—Imipramine—SLC22A4—rheumatoid arthritis	0.000474	0.311	CrCbGaD
Mianserin—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000473	0.00128	CcSEcCtD
Mianserin—Rash—Cyclosporine—rheumatoid arthritis	0.000468	0.00127	CcSEcCtD
Mianserin—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000467	0.00127	CcSEcCtD
Mianserin—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000466	0.00126	CcSEcCtD
Mianserin—Headache—Cyclosporine—rheumatoid arthritis	0.000465	0.00126	CcSEcCtD
Mianserin—Anaemia—Methotrexate—rheumatoid arthritis	0.000464	0.00126	CcSEcCtD
Mianserin—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.000464	0.00126	CcSEcCtD
Mianserin—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.000464	0.00126	CcSEcCtD
Mianserin—Vertigo—Methotrexate—rheumatoid arthritis	0.000451	0.00122	CcSEcCtD
Mianserin—Leukopenia—Methotrexate—rheumatoid arthritis	0.000449	0.00122	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	0.000447	0.00121	CcSEcCtD
Mianserin—Dizziness—Prednisolone—rheumatoid arthritis	0.000446	0.00121	CcSEcCtD
Mianserin—Asthenia—Triamcinolone—rheumatoid arthritis	0.000445	0.00121	CcSEcCtD
Mianserin—Asthenia—Methylprednisolone—rheumatoid arthritis	0.000444	0.0012	CcSEcCtD
Mianserin—Paraesthesia—Prednisone—rheumatoid arthritis	0.00044	0.00119	CcSEcCtD
Mianserin—Pruritus—Triamcinolone—rheumatoid arthritis	0.000439	0.00119	CcSEcCtD
Mianserin—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000438	0.00119	CcSEcCtD
Mianserin—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000436	0.00118	CcSEcCtD
Mianserin—Convulsion—Methotrexate—rheumatoid arthritis	0.000435	0.00118	CcSEcCtD
Mianserin—Arthralgia—Methotrexate—rheumatoid arthritis	0.000427	0.00116	CcSEcCtD
Mianserin—Myalgia—Methotrexate—rheumatoid arthritis	0.000427	0.00116	CcSEcCtD
Mianserin—Rash—Prednisolone—rheumatoid arthritis	0.000425	0.00115	CcSEcCtD
Mianserin—Dermatitis—Prednisolone—rheumatoid arthritis	0.000425	0.00115	CcSEcCtD
Mianserin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.000425	0.00115	CcSEcCtD
Mianserin—Fatigue—Prednisone—rheumatoid arthritis	0.000423	0.00115	CcSEcCtD
Mianserin—Headache—Prednisolone—rheumatoid arthritis	0.000423	0.00115	CcSEcCtD
Mianserin—Constipation—Prednisone—rheumatoid arthritis	0.000419	0.00114	CcSEcCtD
Mianserin—Rash—Hydrocortisone—rheumatoid arthritis	0.000416	0.00113	CcSEcCtD
Mianserin—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000415	0.00113	CcSEcCtD
Mianserin—Confusional state—Methotrexate—rheumatoid arthritis	0.000413	0.00112	CcSEcCtD
Mianserin—Headache—Hydrocortisone—rheumatoid arthritis	0.000413	0.00112	CcSEcCtD
Mianserin—Dizziness—Triamcinolone—rheumatoid arthritis	0.00041	0.00111	CcSEcCtD
Mianserin—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000409	0.00111	CcSEcCtD
Mianserin—Feeling abnormal—Prednisone—rheumatoid arthritis	0.000404	0.0011	CcSEcCtD
Mianserin—Asthenia—Betamethasone—rheumatoid arthritis	0.000404	0.0011	CcSEcCtD
Mianserin—Asthenia—Dexamethasone—rheumatoid arthritis	0.000404	0.0011	CcSEcCtD
Mianserin—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000402	0.00109	CcSEcCtD
Mianserin—Thrombocytopenia—Methotrexate—rheumatoid arthritis	0.000401	0.00109	CcSEcCtD
Mianserin—Pruritus—Betamethasone—rheumatoid arthritis	0.000398	0.00108	CcSEcCtD
Mianserin—Pruritus—Dexamethasone—rheumatoid arthritis	0.000398	0.00108	CcSEcCtD
Mianserin—Skin disorder—Methotrexate—rheumatoid arthritis	0.000398	0.00108	CcSEcCtD
Mianserin—Rash—Triamcinolone—rheumatoid arthritis	0.000391	0.00106	CcSEcCtD
Mianserin—Dermatitis—Triamcinolone—rheumatoid arthritis	0.000391	0.00106	CcSEcCtD
Mianserin—Rash—Methylprednisolone—rheumatoid arthritis	0.00039	0.00106	CcSEcCtD
Mianserin—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.00039	0.00106	CcSEcCtD
Mianserin—Headache—Triamcinolone—rheumatoid arthritis	0.000389	0.00105	CcSEcCtD
Mianserin—Headache—Methylprednisolone—rheumatoid arthritis	0.000388	0.00105	CcSEcCtD
Mianserin—Hypotension—Methotrexate—rheumatoid arthritis	0.000383	0.00104	CcSEcCtD
Mianserin—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	0.000373	0.00101	CcSEcCtD
Mianserin—Dizziness—Betamethasone—rheumatoid arthritis	0.000372	0.00101	CcSEcCtD
Mianserin—Dizziness—Dexamethasone—rheumatoid arthritis	0.000372	0.00101	CcSEcCtD
Mianserin—Paraesthesia—Methotrexate—rheumatoid arthritis	0.000368	0.000998	CcSEcCtD
Mianserin—Somnolence—Methotrexate—rheumatoid arthritis	0.000364	0.000988	CcSEcCtD
Mianserin—Rash—Dexamethasone—rheumatoid arthritis	0.000355	0.000963	CcSEcCtD
Mianserin—Rash—Betamethasone—rheumatoid arthritis	0.000355	0.000963	CcSEcCtD
Mianserin—Dermatitis—Dexamethasone—rheumatoid arthritis	0.000355	0.000962	CcSEcCtD
Mianserin—Dermatitis—Betamethasone—rheumatoid arthritis	0.000355	0.000962	CcSEcCtD
Mianserin—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.000354	0.000959	CcSEcCtD
Mianserin—Fatigue—Methotrexate—rheumatoid arthritis	0.000353	0.000958	CcSEcCtD
Mianserin—Headache—Dexamethasone—rheumatoid arthritis	0.000353	0.000956	CcSEcCtD
Mianserin—Headache—Betamethasone—rheumatoid arthritis	0.000353	0.000956	CcSEcCtD
Mianserin—Asthenia—Prednisone—rheumatoid arthritis	0.000352	0.000954	CcSEcCtD
Mianserin—Pruritus—Prednisone—rheumatoid arthritis	0.000347	0.000941	CcSEcCtD
Mianserin—Feeling abnormal—Methotrexate—rheumatoid arthritis	0.000338	0.000916	CcSEcCtD
Mianserin—Dizziness—Prednisone—rheumatoid arthritis	0.000324	0.000879	CcSEcCtD
Mianserin—Rash—Prednisone—rheumatoid arthritis	0.000309	0.000838	CcSEcCtD
Mianserin—Dermatitis—Prednisone—rheumatoid arthritis	0.000309	0.000837	CcSEcCtD
Mianserin—Headache—Prednisone—rheumatoid arthritis	0.000307	0.000833	CcSEcCtD
Mianserin—Asthenia—Methotrexate—rheumatoid arthritis	0.000294	0.000797	CcSEcCtD
Mianserin—Pruritus—Methotrexate—rheumatoid arthritis	0.00029	0.000786	CcSEcCtD
Mianserin—Dizziness—Methotrexate—rheumatoid arthritis	0.000271	0.000735	CcSEcCtD
Mianserin—Rash—Methotrexate—rheumatoid arthritis	0.000258	0.000701	CcSEcCtD
Mianserin—Dermatitis—Methotrexate—rheumatoid arthritis	0.000258	0.0007	CcSEcCtD
Mianserin—Headache—Methotrexate—rheumatoid arthritis	0.000257	0.000696	CcSEcCtD
Mianserin—Oxcarbazepine—ALB—rheumatoid arthritis	0.000252	0.165	CrCbGaD
Mianserin—Nortriptyline—ALB—rheumatoid arthritis	0.000142	0.0928	CrCbGaD
Mianserin—Amitriptyline—ALB—rheumatoid arthritis	9.83e-05	0.0644	CrCbGaD
Mianserin—HRH1—Signaling Pathways—C3—rheumatoid arthritis	1.67e-05	4.91e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—NOS3—rheumatoid arthritis	1.66e-05	4.9e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—FN1—rheumatoid arthritis	1.64e-05	4.84e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.64e-05	4.84e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—CXCL8—rheumatoid arthritis	1.64e-05	4.83e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL6ST—rheumatoid arthritis	1.64e-05	4.82e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—ALB—rheumatoid arthritis	1.63e-05	4.81e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CD80—rheumatoid arthritis	1.63e-05	4.8e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CD80—rheumatoid arthritis	1.62e-05	4.77e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—CXCL8—rheumatoid arthritis	1.62e-05	4.76e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—CXCL8—rheumatoid arthritis	1.61e-05	4.76e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—CXCL8—rheumatoid arthritis	1.6e-05	4.73e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—POMC—rheumatoid arthritis	1.6e-05	4.72e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—SPP1—rheumatoid arthritis	1.6e-05	4.71e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—CXCL8—rheumatoid arthritis	1.59e-05	4.69e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	1.58e-05	4.66e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—LEP—rheumatoid arthritis	1.58e-05	4.66e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TYK2—rheumatoid arthritis	1.58e-05	4.64e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CD80—rheumatoid arthritis	1.57e-05	4.64e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—TGFB1—rheumatoid arthritis	1.57e-05	4.63e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CCL2—rheumatoid arthritis	1.57e-05	4.62e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IL2—rheumatoid arthritis	1.57e-05	4.62e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL6R—rheumatoid arthritis	1.56e-05	4.6e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—NOS3—rheumatoid arthritis	1.56e-05	4.6e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling by GPCR—IL6—rheumatoid arthritis	1.56e-05	4.59e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—LEP—rheumatoid arthritis	1.56e-05	4.58e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCR5—rheumatoid arthritis	1.56e-05	4.58e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—LEP—rheumatoid arthritis	1.55e-05	4.57e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—NOS3—rheumatoid arthritis	1.55e-05	4.56e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—POMC—rheumatoid arthritis	1.55e-05	4.56e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IL2—rheumatoid arthritis	1.54e-05	4.55e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IL2—rheumatoid arthritis	1.54e-05	4.55e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—TP53—rheumatoid arthritis	1.54e-05	4.53e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—POMC—rheumatoid arthritis	1.54e-05	4.53e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling by GPCR—IL6—rheumatoid arthritis	1.54e-05	4.53e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling by GPCR—IL6—rheumatoid arthritis	1.54e-05	4.52e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IL2—rheumatoid arthritis	1.53e-05	4.52e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL2RA—rheumatoid arthritis	1.53e-05	4.52e-05	CbGpPWpGaD
Mianserin—HRH4—Signaling Pathways—IL6—rheumatoid arthritis	1.53e-05	4.5e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling by GPCR—IL6—rheumatoid arthritis	1.53e-05	4.49e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—IL2—rheumatoid arthritis	1.52e-05	4.48e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—C3—rheumatoid arthritis	1.52e-05	4.48e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CCL2—rheumatoid arthritis	1.51e-05	4.46e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL6R—rheumatoid arthritis	1.51e-05	4.44e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CCL2—rheumatoid arthritis	1.51e-05	4.43e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL6R—rheumatoid arthritis	1.5e-05	4.42e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—POMC—rheumatoid arthritis	1.5e-05	4.41e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—FN1—rheumatoid arthritis	1.49e-05	4.39e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL6ST—rheumatoid arthritis	1.48e-05	4.37e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—MMP9—rheumatoid arthritis	1.48e-05	4.37e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—CXCL8—rheumatoid arthritis	1.48e-05	4.35e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—NFKB1—rheumatoid arthritis	1.47e-05	4.32e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—FN1—rheumatoid arthritis	1.47e-05	4.32e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CCL2—rheumatoid arthritis	1.46e-05	4.31e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—FN1—rheumatoid arthritis	1.46e-05	4.31e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—MMP9—rheumatoid arthritis	1.46e-05	4.31e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL6ST—rheumatoid arthritis	1.46e-05	4.3e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—MMP9—rheumatoid arthritis	1.46e-05	4.3e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL6R—rheumatoid arthritis	1.46e-05	4.3e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL6ST—rheumatoid arthritis	1.46e-05	4.29e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—POMC—rheumatoid arthritis	1.45e-05	4.28e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—MMP9—rheumatoid arthritis	1.45e-05	4.27e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—NFKB1—rheumatoid arthritis	1.45e-05	4.26e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—NFKB1—rheumatoid arthritis	1.44e-05	4.26e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—MAPK8—rheumatoid arthritis	1.44e-05	4.25e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.44e-05	4.23e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—NFKB1—rheumatoid arthritis	1.44e-05	4.23e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CD80—rheumatoid arthritis	1.43e-05	4.21e-05	CbGpPWpGaD
Mianserin—ADRA2C—Metabolism—PTGS2—rheumatoid arthritis	1.43e-05	4.21e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TYK2—rheumatoid arthritis	1.42e-05	4.19e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—MAPK8—rheumatoid arthritis	1.42e-05	4.19e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—MAPK8—rheumatoid arthritis	1.42e-05	4.18e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—CAT—rheumatoid arthritis	1.42e-05	4.18e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—LEP—rheumatoid arthritis	1.41e-05	4.17e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—MAPK8—rheumatoid arthritis	1.41e-05	4.16e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IL2—rheumatoid arthritis	1.41e-05	4.15e-05	CbGpPWpGaD
Mianserin—HTR1F—Signaling Pathways—IL6—rheumatoid arthritis	1.41e-05	4.15e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CD80—rheumatoid arthritis	1.41e-05	4.14e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CD80—rheumatoid arthritis	1.4e-05	4.13e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling by GPCR—IL6—rheumatoid arthritis	1.4e-05	4.13e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—NOS3—rheumatoid arthritis	1.4e-05	4.12e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TYK2—rheumatoid arthritis	1.37e-05	4.05e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—CXCL8—rheumatoid arthritis	1.37e-05	4.04e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TYK2—rheumatoid arthritis	1.37e-05	4.03e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—POMC—rheumatoid arthritis	1.36e-05	4.02e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—POMC—rheumatoid arthritis	1.36e-05	4e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—NOS3—rheumatoid arthritis	1.35e-05	3.97e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—NOS3—rheumatoid arthritis	1.34e-05	3.95e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—POMC—rheumatoid arthritis	1.34e-05	3.94e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—MMP9—rheumatoid arthritis	1.33e-05	3.93e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—FN1—rheumatoid arthritis	1.33e-05	3.93e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—POMC—rheumatoid arthritis	1.33e-05	3.93e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.33e-05	3.92e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TYK2—rheumatoid arthritis	1.33e-05	3.92e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL6ST—rheumatoid arthritis	1.33e-05	3.92e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CCL2—rheumatoid arthritis	1.33e-05	3.91e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—ALB—rheumatoid arthritis	1.33e-05	3.9e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL6R—rheumatoid arthritis	1.32e-05	3.9e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—NFKB1—rheumatoid arthritis	1.32e-05	3.89e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—VEGFA—rheumatoid arthritis	1.31e-05	3.87e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IL2—rheumatoid arthritis	1.31e-05	3.86e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—VEGFA—rheumatoid arthritis	1.31e-05	3.86e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CCL2—rheumatoid arthritis	1.31e-05	3.85e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling by GPCR—IL6—rheumatoid arthritis	1.31e-05	3.85e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—NOS3—rheumatoid arthritis	1.3e-05	3.84e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CCL2—rheumatoid arthritis	1.3e-05	3.84e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL6R—rheumatoid arthritis	1.3e-05	3.84e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—VEGFA—rheumatoid arthritis	1.3e-05	3.84e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL6R—rheumatoid arthritis	1.3e-05	3.83e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—MAPK8—rheumatoid arthritis	1.3e-05	3.82e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—TP53—rheumatoid arthritis	1.29e-05	3.81e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	1.29e-05	3.8e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CD80—rheumatoid arthritis	1.28e-05	3.77e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—NOS3—rheumatoid arthritis	1.27e-05	3.73e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—ALB—rheumatoid arthritis	1.24e-05	3.66e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MMP9—rheumatoid arthritis	1.24e-05	3.66e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—CXCL8—rheumatoid arthritis	1.24e-05	3.65e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—NFKB1—rheumatoid arthritis	1.23e-05	3.62e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.22e-05	3.6e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—POMC—rheumatoid arthritis	1.22e-05	3.58e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—MAPK8—rheumatoid arthritis	1.21e-05	3.56e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TYK2—rheumatoid arthritis	1.21e-05	3.55e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TGFB1—rheumatoid arthritis	1.2e-05	3.55e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TGFB1—rheumatoid arthritis	1.2e-05	3.55e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—CAT—rheumatoid arthritis	1.2e-05	3.54e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—VEGFA—rheumatoid arthritis	1.2e-05	3.53e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—CXCL8—rheumatoid arthritis	1.2e-05	3.52e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TGFB1—rheumatoid arthritis	1.2e-05	3.52e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—CXCL8—rheumatoid arthritis	1.19e-05	3.51e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CCL2—rheumatoid arthritis	1.19e-05	3.5e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—NOS3—rheumatoid arthritis	1.19e-05	3.5e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TYK2—rheumatoid arthritis	1.19e-05	3.5e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL6R—rheumatoid arthritis	1.19e-05	3.49e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TYK2—rheumatoid arthritis	1.18e-05	3.49e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	1.18e-05	3.49e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL2—rheumatoid arthritis	1.18e-05	3.49e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NOS3—rheumatoid arthritis	1.18e-05	3.49e-05	CbGpPWpGaD
Mianserin—HRH2—Signaling Pathways—IL6—rheumatoid arthritis	1.18e-05	3.49e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling by GPCR—IL6—rheumatoid arthritis	1.18e-05	3.47e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NOS3—rheumatoid arthritis	1.17e-05	3.43e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NOS3—rheumatoid arthritis	1.16e-05	3.43e-05	CbGpPWpGaD
Mianserin—ADRA2A—Metabolism—PTGS2—rheumatoid arthritis	1.16e-05	3.42e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—CXCL8—rheumatoid arthritis	1.16e-05	3.41e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL2—rheumatoid arthritis	1.14e-05	3.37e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling by GPCR—IL6—rheumatoid arthritis	1.14e-05	3.35e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL2—rheumatoid arthritis	1.14e-05	3.35e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling by GPCR—IL6—rheumatoid arthritis	1.13e-05	3.33e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MMP9—rheumatoid arthritis	1.12e-05	3.3e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—VEGFA—rheumatoid arthritis	1.11e-05	3.28e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—NFKB1—rheumatoid arthritis	1.11e-05	3.27e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL2—rheumatoid arthritis	1.11e-05	3.26e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling by GPCR—IL6—rheumatoid arthritis	1.1e-05	3.24e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TGFB1—rheumatoid arthritis	1.1e-05	3.24e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—MAPK8—rheumatoid arthritis	1.09e-05	3.21e-05	CbGpPWpGaD
Mianserin—CYP2B6—Metabolism—PTGS2—rheumatoid arthritis	1.09e-05	3.2e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MMP9—rheumatoid arthritis	1.08e-05	3.19e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TYK2—rheumatoid arthritis	1.08e-05	3.18e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MMP9—rheumatoid arthritis	1.08e-05	3.17e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—NFKB1—rheumatoid arthritis	1.07e-05	3.15e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—NFKB1—rheumatoid arthritis	1.07e-05	3.14e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NOS3—rheumatoid arthritis	1.06e-05	3.12e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—MAPK8—rheumatoid arthritis	1.05e-05	3.1e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—CXCL8—rheumatoid arthritis	1.05e-05	3.09e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MMP9—rheumatoid arthritis	1.05e-05	3.08e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—MAPK8—rheumatoid arthritis	1.05e-05	3.08e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—NFKB1—rheumatoid arthritis	1.04e-05	3.05e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—CXCL8—rheumatoid arthritis	1.03e-05	3.04e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—CXCL8—rheumatoid arthritis	1.03e-05	3.04e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TGFB1—rheumatoid arthritis	1.02e-05	3.01e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—MAPK8—rheumatoid arthritis	1.02e-05	3e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—VEGFA—rheumatoid arthritis	1.01e-05	2.97e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—TP53—rheumatoid arthritis	1.01e-05	2.96e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL2—rheumatoid arthritis	1e-05	2.96e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	1e-05	2.96e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling by GPCR—IL6—rheumatoid arthritis	9.99e-06	2.94e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—TP53—rheumatoid arthritis	9.92e-06	2.92e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—TP53—rheumatoid arthritis	9.91e-06	2.92e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL2—rheumatoid arthritis	9.88e-06	2.91e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL2—rheumatoid arthritis	9.86e-06	2.9e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—TP53—rheumatoid arthritis	9.84e-06	2.9e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling by GPCR—IL6—rheumatoid arthritis	9.83e-06	2.9e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling by GPCR—IL6—rheumatoid arthritis	9.81e-06	2.89e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—VEGFA—rheumatoid arthritis	9.72e-06	2.86e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—VEGFA—rheumatoid arthritis	9.67e-06	2.85e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MMP9—rheumatoid arthritis	9.5e-06	2.8e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—POMC—rheumatoid arthritis	9.47e-06	2.79e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—CXCL8—rheumatoid arthritis	9.4e-06	2.77e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—VEGFA—rheumatoid arthritis	9.4e-06	2.77e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—NFKB1—rheumatoid arthritis	9.4e-06	2.77e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MMP9—rheumatoid arthritis	9.35e-06	2.75e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MMP9—rheumatoid arthritis	9.33e-06	2.75e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—CAT—rheumatoid arthritis	9.28e-06	2.73e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—NFKB1—rheumatoid arthritis	9.25e-06	2.72e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—MAPK8—rheumatoid arthritis	9.24e-06	2.72e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TGFB1—rheumatoid arthritis	9.24e-06	2.72e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—NFKB1—rheumatoid arthritis	9.23e-06	2.72e-05	CbGpPWpGaD
Mianserin—OPRK1—Signaling Pathways—IL6—rheumatoid arthritis	9.21e-06	2.71e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—MAPK8—rheumatoid arthritis	9.09e-06	2.68e-05	CbGpPWpGaD
Mianserin—HTR6—Signaling Pathways—IL6—rheumatoid arthritis	9.08e-06	2.67e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—MAPK8—rheumatoid arthritis	9.07e-06	2.67e-05	CbGpPWpGaD
Mianserin—HTR7—Signaling Pathways—IL6—rheumatoid arthritis	9.07e-06	2.67e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—TP53—rheumatoid arthritis	9.05e-06	2.67e-05	CbGpPWpGaD
Mianserin—HTR1D—Signaling Pathways—IL6—rheumatoid arthritis	9.01e-06	2.65e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL2—rheumatoid arthritis	8.99e-06	2.65e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling by GPCR—IL6—rheumatoid arthritis	8.94e-06	2.63e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TGFB1—rheumatoid arthritis	8.92e-06	2.63e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TGFB1—rheumatoid arthritis	8.87e-06	2.61e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—ALB—rheumatoid arthritis	8.64e-06	2.54e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TGFB1—rheumatoid arthritis	8.63e-06	2.54e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—VEGFA—rheumatoid arthritis	8.53e-06	2.51e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MMP9—rheumatoid arthritis	8.5e-06	2.51e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—TP53—rheumatoid arthritis	8.42e-06	2.48e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—NFKB1—rheumatoid arthritis	8.41e-06	2.48e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—VEGFA—rheumatoid arthritis	8.39e-06	2.47e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—VEGFA—rheumatoid arthritis	8.38e-06	2.47e-05	CbGpPWpGaD
Mianserin—HTR2B—Signaling Pathways—IL6—rheumatoid arthritis	8.29e-06	2.44e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—MAPK8—rheumatoid arthritis	8.27e-06	2.44e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	8.26e-06	2.43e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—POMC—rheumatoid arthritis	8.02e-06	2.36e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TGFB1—rheumatoid arthritis	7.83e-06	2.31e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	7.74e-06	2.28e-05	CbGpPWpGaD
Mianserin—DRD3—Signaling Pathways—IL6—rheumatoid arthritis	7.71e-06	2.27e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TGFB1—rheumatoid arthritis	7.7e-06	2.27e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TGFB1—rheumatoid arthritis	7.69e-06	2.26e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—VEGFA—rheumatoid arthritis	7.64e-06	2.25e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—TP53—rheumatoid arthritis	7.61e-06	2.24e-05	CbGpPWpGaD
Mianserin—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	7.55e-06	2.23e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—TP53—rheumatoid arthritis	7.34e-06	2.16e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—ALB—rheumatoid arthritis	7.32e-06	2.16e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—TP53—rheumatoid arthritis	7.3e-06	2.15e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—TP53—rheumatoid arthritis	7.1e-06	2.09e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TGFB1—rheumatoid arthritis	7.01e-06	2.07e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	7e-06	2.06e-05	CbGpPWpGaD
Mianserin—ADRA2B—Signaling Pathways—IL6—rheumatoid arthritis	6.96e-06	2.05e-05	CbGpPWpGaD
Mianserin—HTR1A—Signaling Pathways—IL6—rheumatoid arthritis	6.72e-06	1.98e-05	CbGpPWpGaD
Mianserin—HTR2C—Signaling Pathways—IL6—rheumatoid arthritis	6.69e-06	1.97e-05	CbGpPWpGaD
Mianserin—ADRA2C—Signaling Pathways—IL6—rheumatoid arthritis	6.5e-06	1.92e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—TP53—rheumatoid arthritis	6.45e-06	1.9e-05	CbGpPWpGaD
Mianserin—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	6.4e-06	1.89e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—TP53—rheumatoid arthritis	6.34e-06	1.87e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—TP53—rheumatoid arthritis	6.33e-06	1.86e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—POMC—rheumatoid arthritis	6.19e-06	1.82e-05	CbGpPWpGaD
Mianserin—DRD2—Signaling Pathways—IL6—rheumatoid arthritis	5.9e-06	1.74e-05	CbGpPWpGaD
Mianserin—HTR2A—Signaling Pathways—IL6—rheumatoid arthritis	5.81e-06	1.71e-05	CbGpPWpGaD
Mianserin—HRH1—Signaling Pathways—IL6—rheumatoid arthritis	5.79e-06	1.71e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—TP53—rheumatoid arthritis	5.77e-06	1.7e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—ALB—rheumatoid arthritis	5.65e-06	1.66e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	5.4e-06	1.59e-05	CbGpPWpGaD
Mianserin—ADRA2A—Signaling Pathways—IL6—rheumatoid arthritis	5.28e-06	1.56e-05	CbGpPWpGaD
Mianserin—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	4.94e-06	1.46e-05	CbGpPWpGaD
